369 related articles for article (PubMed ID: 32693759)
1. Targeting Toll like Receptors in Cancer: Role of TLR Natural and Synthetic Modulators.
Narayanankutty A; Sasidharan A; Job JT
Curr Pharm Des; 2020; 26(39):5040-5053. PubMed ID: 32693759
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptors Signaling in the Tumor Microenvironment.
McCall KD; Muccioli M; Benencia F
Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
[TBL] [Abstract][Full Text] [Related]
3. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
4. Application potential of toll-like receptors in cancer immunotherapy: Systematic review.
Shi M; Chen X; Ye K; Yao Y; Li Y
Medicine (Baltimore); 2016 Jun; 95(25):e3951. PubMed ID: 27336891
[TBL] [Abstract][Full Text] [Related]
5. The Yin and Yang of Toll-like receptors in cancer.
Pradere JP; Dapito DH; Schwabe RF
Oncogene; 2014 Jul; 33(27):3485-95. PubMed ID: 23934186
[TBL] [Abstract][Full Text] [Related]
6. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
Goulopoulou S; McCarthy CG; Webb RC
Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
[TBL] [Abstract][Full Text] [Related]
7. Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.
Bryant CE; Gay NJ; Heymans S; Sacre S; Schaefer L; Midwood KS
Crit Rev Biochem Mol Biol; 2015; 50(5):359-79. PubMed ID: 25857820
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.
Vidya MK; Kumar VG; Sejian V; Bagath M; Krishnan G; Bhatta R
Int Rev Immunol; 2018 Jan; 37(1):20-36. PubMed ID: 29028369
[TBL] [Abstract][Full Text] [Related]
9. A systematic literature review on the effects of exercise on human Toll-like receptor expression.
Favere K; Bosman M; Delputte PL; Favoreel HW; Van Craenenbroeck EM; De Sutter J; Witvrouwen I; De Meyer GRY; Heidbuchel H; Guns PDF
Exerc Immunol Rev; 2021; 27():84-124. PubMed ID: 33965901
[TBL] [Abstract][Full Text] [Related]
10. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors, inflammation and cancer.
Tsan MF
Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
[TBL] [Abstract][Full Text] [Related]
12. Interdependencies between Toll-like receptors in Leishmania infection.
Shukla D; Patidar A; Sarma U; Chauhan P; Pandey SP; Chandel HS; Bodhale N; Ghosh SK; Guzman CA; Ebensen T; Silvestre R; Sarkar A; Saha B; Bhattacharjee S
Immunology; 2021 Sep; 164(1):173-189. PubMed ID: 33964011
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors.
Takeda K; Akira S
Curr Protoc Immunol; 2015 Apr; 109():14.12.1-14.12.10. PubMed ID: 25845562
[TBL] [Abstract][Full Text] [Related]
14. Targeting Toll-like receptors with small molecule agents.
Wang X; Smith C; Yin H
Chem Soc Rev; 2013 Jun; 42(12):4859-66. PubMed ID: 23503527
[TBL] [Abstract][Full Text] [Related]
15. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
16. Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
Agarwal M; Kumar M; Pathak R; Bala K; Kumar A
Int Rev Cell Mol Biol; 2024; 385():227-261. PubMed ID: 38663961
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor signalling as a cannabinoid target.
Cui Sun M; Otálora-Alcaraz A; Prenderville JA; Downer EJ
Biochem Pharmacol; 2024 Apr; 222():116082. PubMed ID: 38438052
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors and kidney diseases.
Eleftheriadis T; Lawson BR
Inflamm Allergy Drug Targets; 2009 Jul; 8(3):191-201. PubMed ID: 19601879
[TBL] [Abstract][Full Text] [Related]
20. Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics.
Jin M; Fang J; Wang JJ; Shao X; Xu SW; Liu PQ; Ye WC; Liu ZP
Acta Pharmacol Sin; 2023 Dec; 44(12):2358-2375. PubMed ID: 37550526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
